| Literature DB >> 35915323 |
Andreas A Giannopoulos1, Ronny R Buechel1, Philipp A Kaufmann2.
Abstract
Pathologic hypertrophy of the cardiac muscle is a commonly encountered phenotype in clinical practice, associated with a variety of structural and non-structural diseases. Coronary microvascular disease is considered to play an important role in the natural history of this pathological phenotype. Non-invasive imaging modalities, most prominently positron emission tomography and cardiac magnetic resonance, have provided insights into the pathophysiological mechanisms of the interplay between hypertrophy and the coronary microvasculature. This article summarizes the current knowledge on coronary microvascular dysfunction in the most frequently encountered forms of pathologic hypertrophy.Entities:
Keywords: CMD; CMR; Coronary microvascular disease; cardiac PET; coronary flow reserve; left ventricular hypertrophy
Year: 2022 PMID: 35915323 DOI: 10.1007/s12350-022-03040-2
Source DB: PubMed Journal: J Nucl Cardiol ISSN: 1071-3581 Impact factor: 3.872